Maximus (NYSE:MMS) Stock, Quote.Headers.trade-ideas

Maximus

Maximus Inc designs, develops, and delivers programs, enabling people to access vital government services. It translates health and human services public policy into operating models that achieve outcomes for governments at scale. The company covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. The company operates through the following segments; U.S. Federal Services, U.S. Services, and Outside the U.S. A majority of its revenue is derived from the U.S. Federal Services segment which engages with various U.S. federal government agencies to deliver clinical services, maintenance services, and technology solutions.

Wall Street

News

Upgrades

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

This Cloudflare Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday

trader ai2

Equities

Health Care

General

Maximus announces CMS has canceled the early re-procurement of its Medicare contract, allowing the company to continue its current work until 2031.

Maximus Secures Medicare Contract Through 2031, Shares Gain Momentum

maximus shutter

Government

After-Hours Center

Movers

Maximus shares are bouncing around in extended trading Tuesday after the company announced the cancellation of a contact center operations contract.

Maximus Stock Bounces Around After Hours Tuesday: What&#39;s Going On?

Maximus Inc

IndexIQ Active ETF Trust IQ MacKay Multi-Sector Income ETF

MEGMILK SNOW BRAND CO LTD by MEGMILK SNOW BRAND CO LTD.

Megmilk Snow Brand Co Ltd

First Trust Multi-Manager Small Cap Opportunities ETF

MACARTHUR MINERALS LTD by Macarthur Minerals Ltd.

MCMILLAN SHAKESPEARE ADR by McMillan Shakespeare Ltd

McMillan Shakespeare Ltd

Merit Medical Systems, Inc. - Common Stock

Merit Medical Systems Inc

Macarthur Minerals Ltd

MITSU MNG&SMLTNG UNSP/ADR by Mitsu Mining & Smelting Co., Ltd.

Mitsui Mining and Smelting Co Ltd

Mirrored Microsoft

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Goldman Sachs analyst Gabriela Borges upgraded the rating for Cloudflare, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NET#NYSE">NET</a>) from Sell to Buy and raised the price target from $77 to $140. Cloudflare shares closed at $107.68 on Tuesday. <a href="https://www.benzinga.com/quote/NET/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Raymond James analyst Brian Gesuale upgraded Maximus, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMS#NYSE">MMS</a>) from Market Perform to Outperform and announced a $90 price target. Maximus shares closed at $74.65 on Tuesday. <a href="https://www.benzinga.com/quote/MMS/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>DA Davidson analyst Peter Winter upgraded U.S. Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USB#NYSE">USB</a>) from Neutral to Buy and increased the price target from $58 to $60. U.S. Bancorp shares closed at $47.83 on Tuesday. <a href="https://www.benzinga.com/quote/USB/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Evercore ISI Group analyst Vijay Kumar upgraded the rating for Mettler-Toledo International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTD#NYSE">MTD</a>) from In-Line to Outperform and raised the price target from $1375 to $1450. Mettler-Toledo Intl shares closed at $1,223.68 on Tuesday. <a href="https://www.benzinga.com/quote/MTD/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barclays analyst Nicholas Campanella upgraded Edison International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EIX#NYSE">EIX</a>) from Equal-Weight to Overweight but lowered the price target from $91 to $84. Edison Intl shares closed at $79.84 on Friday. <a href="https://www.benzinga.com/quote/EIX/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying NET stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="590" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/02080622/image-6-1024x590.png" alt="" class="wp-image-715066" style="width:585px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/02080622/image-6-1024x590.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/02080622/image-6-300x173.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/02080622/image-6-768x442.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/02080622/image-6.png 1111w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/12/42740135/how-to-earn-500-a-month-from-alphabet-stock">How To Earn $500 A Month From Alphabet Stock</a></li>
</ul>

Raymond James analyst Brian Gesuale upgrades Maximus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMS#NYSE">MMS</a>) from Market Perform to Outperform and announces $90 price target.

Price Target

Raymond James Upgrades Maximus to Outperform, Announces $90 Price Target

Buybacks

Maximus Board Authorizes $200M Increase Common Stock Purchase Program

On December 5, a recent SEC filing unveiled that Michelle Link, Chief Human Resources at Maximus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMS#NYSE">MMS</a>) made an insider sell.
What Happened: Link's recent move involves selling 2,208 shares of Maximus. This information is documented in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001032220/000095017024133496//Archives/edgar/data/1032220/000095017024133496/0000950170-24-133496-index.htm">U.S. Securities and Exchange Commission</a> on Thursday. The total value is $163,016.
As of Thursday morning, Maximus shares are down by 0.0%, currently priced at $74.66.
<h3>About Maximus</h3>
Maximus Inc designs, develops, and delivers programs, enabling people to access vital government services. It translates health and human services public policy into operating models that achieve outcomes for governments at scale. The company covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. The company operates through the following segments; U.S. Federal Services, U.S. Services, and Outside the U.S. A majority of its revenue is derived from the U.S. Federal Services segment which engages with various U.S. federal government agencies to deliver clinical services, maintenance services, and technology solutions.
<h3>Financial Insights: Maximus</h3>
Revenue Growth: Over the 3 months period, Maximus showcased positive performance, achieving a revenue growth rate of 4.44% as of 30 September, 2024. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Industrials sector.
Profitability Metrics:
<ul>
<li>
Gross Margin: With a low gross margin of 22.93%, the company exhibits below-average profitability, signaling potential struggles in cost efficiency compared to its industry peers.
</li>
<li>
Earnings per Share (EPS): Maximus's EPS is notably higher than the industry average. The company achieved a positive bottom-line trend with a current EPS of 1.2.
</li>
</ul>
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.69.
In-Depth Valuation Examination:
<ul>
<li>
Price to Earnings (P/E) Ratio: Maximus's P/E ratio of 14.96 is below the industry average, suggesting the stock may be undervalued.
</li>
<li>
Price to Sales (P/S) Ratio: The Price to Sales ratio is 0.87, which is lower than the industry average. This suggests a possible undervaluation based on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): The company's EV/EBITDA ratio of 9.05 trails industry averages, indicating a potential disparity in market valuation that could be advantageous for investors.
</li>
</ul>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Why Pay Attention to Insider Transactions</h3>
Insider transactions should be considered alongside other factors when making investment decisions, as they can offer important insights.
When discussing legal matters, the term "insider" refers to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as stipulated in Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and significant hedge funds. Such insiders are required to report their transactions through a Form 4 filing, which must be completed within two business days of the transaction.
A new purchase by a company insider is a indication that they anticipate the stock will rise.
On the other hand, insider sells may not necessarily indicate a bearish view and can be motivated by various factors.
<h3>Essential Transaction Codes Unveiled</h3>
Navigating through the landscape of transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often prioritize those unfolding in the open market, precisely detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001032220">Check Out The Full List Of Maximus's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;utm_source=benzinga-insights">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

Sell Alert: Michelle Link Cashes Out $163K In Maximus Stock

Maximus, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMS#NYSE">MMS</a>) shares are<a href="https://www.benzinga.com/general/health-care/24/11/42203859/maximus-stock-bounces-around-after-hours-tuesday-whats-going-on" target="_blank" rel="noreferrer noopener"> trading higher on Wednesday.</a>
Today, the company announced that the U.S. Department of Health and Human Services, Centers for Medicare &amp; Medicaid Services (CMS) has withdrawn their early re-procurement of the Contact Center Operations (CCO) 1-800-MEDICARE <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/b42205421/maximus-will-continue-to-perform-contact-center-operations-contract" rel="noreferrer noopener">and Federal Marketplace contract</a>.
The early re-procurement of the contract would have otherwise caused Maximus to recompete for the same scope of work it currently performs under its contract today, the company said.
The current contract retains its available option periods until 2031.
Also Read: <a target="_blank" href="https://www.benzinga.com/24/11/42211820/whats-going-on-with-teslas-chinese-rival-nio-stock-today" rel="noreferrer noopener">What&#8217;s Going On With Tesla&#8217;s Chinese Rival NIO Stock Today?</a>
&#8220;We are pleased with this outcome and appreciate the opportunity to continue supporting HHS and CMS in their vital missions and look forward to delivering innovative, high-quality, and reliable solutions that benefit the American public,&#8221; said Bruce Caswell, president and CEO of Maximus.
&#8220;Maximus employees have consistently demonstrated their ability to successfully manage this critical program providing essential support to more than 75 million eligible Americans who rely on Medicare and the Federal Marketplace,&#8221; Caswell said.
For FY25, Maximus sees revenues between $5.275 billion and $5.425 billion<a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/b42099110/maximus-reports-fourth-quarter-and-full-year-results-for-fiscal-year-2024" rel="noreferrer noopener"> (estimate: $5.297 billion)</a>. Adjusted diluted earnings per share, which excludes expense for amortization of intangible assets and divestiture-related charges, is expected to range between $5.70 and $6.00 per share (estimate: $5.07).
Price Action: MMS shares were up 0.5% to $73.34 at last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/42170135/its-the-most-wonderful-time-of-the-year-for-the-stock-market-history-says" target="_blank" rel="noreferrer noopener">‘It&#8217;s The Most Wonderful Time Of The Year&#8217; For The Stock Market, History Says</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fmaximus.com%2F&amp;esheet=54158762&amp;newsitemid=20241126626604&amp;lan=en-US&amp;anchor=Maximus&amp;index=1&amp;md5=26f28e5ecebffe14bcf89e1d5a14ed8b">Maximus</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMS#NYSE">MMS</a>) is pleased to announce that the U.S. Department of Health and Human Services, Centers for Medicare &amp; Medicaid Services (CMS) has withdrawn their early re-procurement of the Contact Center Operations (CCO) 1-800-MEDICARE and Federal Marketplace contract. The early re-procurement of the contract would have otherwise caused Maximus to recompete for the same scope of work it currently performs under its contract today. The current contract retains its available option periods until 2031.

Reported Earlier, Maximus Retains Key CMS Contract, Securing Contact Center Operations Through 2031

Maximus Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMS#NYSE">MMS</a>) shares are volatile in extended trading Tuesday after the company announced the cancellation of a <a href="https://www.benzinga.com/pressreleases/24/11/b42201228/u-s-department-of-health-and-human-services-centers-for-medicare-and-medicaid-services-notify-maxi">contact center operations contract</a>.
What Happened: After the market close on Tuesday, Maximus said it received notification from the U.S. Department of Health and Human Services, Centers for Medicare and Medicaid Services (CMS) that the federal agency has canceled the Contact Center Operations (CCO) 1-800-MEDICARE and Federal Marketplace solicitation.
The company said the contract covered the same scope of work Maximus currently performs under separate contracts through option periods available until 2031.
&#8220;Maximus employees have consistently demonstrated their ability to successfully manage this critical program providing essential support to more than 75 million eligible Americans who rely on Medicare and the Federal Marketplace,&#8221; said Bruce Caswell, president and CEO of Maximus.
&#8220;We appreciate the opportunity to continue supporting HHS and CMS in their vital missions and look forward to delivering innovative, high-quality, and reliable solutions that benefit the American public.&#8221;
Maximus helps improve the delivery of public services&nbsp;as a strategic partner to governments around the world.
MMS Price Action: Maximus shares were volatile at the start of the after-hours session, but were trading approximately flat by the time of publication Tuesday at $73, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/11/42202858/workday-stock-slides-after-q3-results-beat-expectations-fy-subscription-revenue-guidance-revised-lower">Workday Stock Slides After Q3 Results Beat Expectations, FY Subscription Revenue Guidance Revised Lower</a></li>
</ul>
Photo: Shutterstock.

Maximus Stock Bounces Around After Hours Tuesday: What's Going On?

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fmaximus.com&amp;esheet=54158662&amp;newsitemid=20241126053073&amp;lan=en-US&amp;anchor=Maximus&amp;index=1&amp;md5=a7d9f87c1b7dd3fbe9a85187dc328bbe">Maximus</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMS#NYSE">MMS</a>), a leading employer and provider of government services worldwide, announced the U.S. Department of Health and Human Services, Centers for Medicare and Medicaid Services (CMS) notified Maximus they have cancelled the Contact Center Operations (CCO) 1-800-MEDICARE and Federal Marketplace solicitation which covered the same scope of work Maximus currently performs under contract today through option periods available until 2031.

Biotech

U.S. Department Of Health And Human Services, Centers For Medicare And Medicaid Services Notify Maximus Of Cancellation Of The Contact Center Operations Contract Re-Procurement

Maximus Shares Halted On Circuit Breaker To The Downside, Stock Now Down -0.77%

WIIM

Maximus shares are trading lower after the company on Wednesday reported worse-than-expected Q4 adjusted EPS results.

U.S. stock futures were higher this morning, with the Dow futures gaining more than 100 points on Thursday.
Shares of Maximus, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMS#NYSE">MMS</a>) fell sharply in today's pre-market trading after the company reported <a href="https://www.benzinga.com/quote/MMS/earnings">worse-than-expected fourth-quarter adjusted EPS results.</a>
Maximus reported quarterly earnings of $1.46 per share which missed the analyst consensus estimate of $1.50 per share. The company reported quarterly sales of $1.32 billion which beat the analyst consensus estimate of $1.31 billion.
Maximus shares dipped 4.4% to $76.99 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul>
<li>Kura Oncology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KURA#NASDAQ">KURA</a>) shares declined 16.7% to $13.25 in pre-market trading. Kura Oncology and Kyowa Kirin announced a global strategic collaboration to develop and commercialize Ziftomenib in Acute Leukemias.</li>
<li>Atkore Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATKR#NASDAQ">ATKR</a>) shares dipped 9.7% to $76.00 in pre-market trading after the company reported downbeat fourth-quarter earnings.</li>
<li>Cool Company Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLCO#NASDAQ">CLCO</a>) fell 9.7% to $9.59 in pre-market trading after the company announced third-quarter results.</li>
<li>Centessa Pharmaceuticals plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNTA#NASDAQ">CNTA</a>) fell 9.7% to $15.10 in today's pre-market trading.</li>
<li>Xponential Fitness, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPOF#NYSE">XPOF</a>) fell 8.7% to $14.01 in pre-market trading.</li>
<li>PDD Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>) fell 7.1% to $108.20 in pre-market trading following weak quarterly results.</li>
<li>Scholastic Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCHL#NASDAQ">SCHL</a>) fell 2.4% to $24.21 in pre-market trading.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/11/42103475/nvidia-deere-and-3-stocks-to-watch-heading-into-thursday">Nvidia, Deere And 3 Stocks To Watch Heading Into Thursday</a></li>
</ul>

ATKR

CLCO

CNTA

KURA

Citigourp Global Markets 2% Protected Notes Linked To The Djia

SCHL

XPOF

Maximus Reports Weak Earnings, Joins Atkore, PDD Holdings And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Maximus shares are trading lower after the company reported worse-than-expected Q4 adjusted EPS results.

Guidance

Maximus Sees FY25 Revenue $5.275-$5.425B Vs $5.297B Est.; FCF $345M-$375M

Maximus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMS#NYSE">MMS</a>) reported quarterly earnings of $1.46 per share which missed the analyst consensus estimate of $1.50 by 2.67 percent. The company reported quarterly sales of $1.32 billion which beat the analyst consensus estimate of $1.31 billion by 1.00 percent. This is a 4.76 percent increase over sales of $1.26 billion the same period last year.

Earnings

Earnings Beats

Earnings Misses

Maximus Q4 2024 Adj EPS $1.46 Misses $1.50 Estimate, Sales $1.32B Beat $1.31B Estimate

<h3>Companies Reporting Before The Bell</h3>
• Williams-Sonoma (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WSM#NYSE">WSM</a>) is expected to report quarterly earnings at $1.78 per share on revenue of $1.79 billion. 
• Cool Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLCO#NYSE">CLCO</a>) is projected to report quarterly earnings at $0.39 per share on revenue of $81.87 million. 
• TJX Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TJX#NYSE">TJX</a>) is expected to report quarterly earnings at $1.10 per share on revenue of $13.95 billion. 
• Global E Online (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLBE#NASDAQ">GLBE</a>) is likely to report quarterly loss at $0.15 per share on revenue of $168.60 million. 
• ZIM Integrated Shipping (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIM#NYSE">ZIM</a>) is likely to report quarterly earnings at $7.21 per share on revenue of $2.41 billion. 
• Spire (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SR#NYSE">SR</a>) is projected to report quarterly loss at $0.53 per share on revenue of $349.50 million. 
• Dycom Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DY#NYSE">DY</a>) is likely to report quarterly earnings at $2.26 per share on revenue of $1.22 billion. 
• Canaan (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAN#NASDAQ">CAN</a>) is projected to report quarterly loss at $0.15 per share on revenue of $72.77 million. 
• So-Young Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SY#NASDAQ">SY</a>) is expected to report earnings for its third quarter. 
• Yatsen Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YSG#NYSE">YSG</a>) is expected to report earnings for its third quarter. 
• ATRenew (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RERE#NYSE">RERE</a>) is expected to report quarterly earnings at $0.05 per share on revenue of $561.74 million. 
• Full Truck Alliance Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YMM#NYSE">YMM</a>) is projected to report quarterly earnings at $0.15 per share on revenue of $388.51 million. 
• Wix.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WIX#NASDAQ">WIX</a>) is estimated to report quarterly earnings at $1.43 per share on revenue of $443.96 million. 
• Target (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>) is projected to report quarterly earnings at $2.30 per share on revenue of $25.90 billion. 
• NIO (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>) is projected to report quarterly loss at $0.32 per share on revenue of $2.70 billion. 
• Nano Dimension (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNDM#NASDAQ">NNDM</a>) is projected to report earnings for its third quarter. 
• Yiren Digital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YRD#NYSE">YRD</a>) is estimated to report earnings for its third quarter. 
• DouYu Intl Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOYU#NASDAQ">DOYU</a>) is likely to report earnings for its third quarter. 
• Naas Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAAS#NASDAQ">NAAS</a>) is estimated to report earnings for its third quarter. 
• Jiayin Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JFIN#NASDAQ">JFIN</a>) is expected to report earnings for its third quarter. 
<h3>Companies Reporting After The Bell</h3>
• Copa Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPA#NYSE">CPA</a>) is expected to report quarterly earnings at $3.43 per share on revenue of $860.65 million. 
• Corporacion America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAAP#NYSE">CAAP</a>) is likely to report quarterly earnings at $0.18 per share on revenue of $400.00 million. 
• Banco BBVA Argentina (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBAR#NYSE">BBAR</a>) is projected to report quarterly earnings at $0.45 per share on revenue of $583.60 million. 
• VNET Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VNET#NASDAQ">VNET</a>) is likely to report quarterly earnings at $0.03 per share on revenue of $286.47 million. 
• Euroseas (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ESEA#NASDAQ">ESEA</a>) is likely to report quarterly earnings at $3.55 per share on revenue of $53.30 million. 
• Universal Technical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UTI#NYSE">UTI</a>) is projected to report quarterly earnings at $0.24 per share on revenue of $191.24 million. 
• Snowflake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>) is estimated to report quarterly earnings at $0.15 per share on revenue of $898.46 million. 
• Maximus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMS#NYSE">MMS</a>) is estimated to report quarterly earnings at $1.48 per share on revenue of $1.31 billion. 
• Jack In The Box (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JACK#NASDAQ">JACK</a>) is likely to report quarterly earnings at $1.09 per share on revenue of $356.86 million. 
• KinderCare Learning (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KLC#NYSE">KLC</a>) is projected to report quarterly loss at $0.02 per share on revenue of $669.45 million. 
• NVIDIA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) is likely to report quarterly earnings at $0.75 per share on revenue of $33.12 billion. 
• Jewett-Cameron Trading (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JCTC#NASDAQ">JCTC</a>) is projected to report earnings for its fourth quarter. 
• Duos Technologies Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DUOT#NASDAQ">DUOT</a>) is projected to report quarterly loss at $0.25 per share on revenue of $2.80 million. 
• Intchains Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICG#NASDAQ">ICG</a>) is expected to report quarterly earnings at $0.05 per share on revenue of $14.32 million. 
• Palo Alto Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANW#NASDAQ">PANW</a>) is expected to report quarterly earnings at $1.48 per share on revenue of $2.12 billion. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BBAR

CAAP

DOYU

DUOT

ESEA

GLBE

JACK

JCTC

JFIN

NAAS

NNDM

NVDA

PANW

RERE

SNOW

VNET

Earnings Scheduled For November 20, 2024

Maximus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMS#NYSE">MMS</a>) is gearing up to announce its quarterly earnings on Wednesday, 2024-11-20. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Maximus will report an earnings per share (EPS) of $1.48.
The announcement from Maximus is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
<h3>Historical Earnings Performance</h3>
Last quarter the company beat EPS by $0.40, which was followed by a 0.22% drop in the share price the next day.
Here's a look at Maximus's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.34</td>
<td>1.02</td>
<td>1.01</td>
<td>1.03</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.74</td>
<td>1.57</td>
<td>1.34</td>
<td>1.29</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-0.0%</td>
<td>-1.0%</td>
<td>1.0%</td>
<td>5.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1732026157_0.png" alt="eps graph" />
<h3>Tracking Maximus's Stock Performance</h3>
Shares of Maximus were trading at $79.23 as of November 15. Over the last 52-week period, shares are down 4.86%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<a href="https://www.benzinga.com/quote/MMS/earnings">To track all earnings releases for Maximus visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Look at Maximus's Upcoming Earnings Report

Maximus Secures Spot On $300M IRS Consulting Services Blanket Purchase Agreement, Enabling Strategic Planning And Business Process Improvement To Enhance Taxpayer Services Over A Five-Year Term

Maximus expands role under second EDOS task order delivering modernized services for the IRS Enterprise Data Platform (EDP)
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fmaximus.com&amp;esheet=54120626&amp;newsitemid=20240912135262&amp;lan=en-US&amp;anchor=Maximus&amp;index=1&amp;md5=34f38517397592c0a467ab7831594e6f">Maximus</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMS#NYSE">MMS</a>), a leading employer and provider of government services worldwide, today announced it has been awarded a five-year, $40 million task order by the Internal Revenue Service (IRS) to deliver end-to-end development and modernization services for the IRS Enterprise Data Platform (EDP).
The IRS awarded Maximus the task order through the Blanket Purchase Agreement (BPA) for the Enterprise Development, Operations Services (EDOS) contract, which supports the agency's modernization plans for delivering world-class customer service to taxpayers. Previously, the IRS named Maximus to the <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fmaximus.com%2Fnews%2Fmaximus-awarded-transformational-irs-enterprise-development-operations-service-edos-contract&amp;esheet=54120626&amp;newsitemid=20240912135262&amp;lan=en-US&amp;anchor=multiple-award+BPA+in+May+2023&amp;index=2&amp;md5=34f15849cc2830bbc785f89bae3050ac">multiple-award BPA in May 2023</a>. This is the second task order for Maximus through EDOS, having announced an <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestor.maximus.com%2Fnews-events%2Fpress-releases%2Fdetail%2F542%2Fmaximus-awarded-87-million-task-order-under-irs&amp;esheet=54120626&amp;newsitemid=20240912135262&amp;lan=en-US&amp;anchor=%2487+million+task+order+in+June&amp;index=3&amp;md5=66fb4a6914c142d01285ded6e515b6b4">$87 million task order in June</a> for modernization of the IRS Suite of Financial Systems.

Contracts

Maximus Awarded 5-Year $40M Task Order By The IRS To Deliver End-To-End Development And Modernization Services For The IRS Enterprise Data Platform

Maximus is Contact Center Services Provider for new program launching in November
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fmaximus.com&amp;esheet=54113478&amp;newsitemid=20240827600267&amp;lan=en-US&amp;anchor=Maximus&amp;index=1&amp;md5=368aa40e8098be2e69e4bebae1b2478c">Maximus</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMS#NYSE">MMS</a>), a leading employer and provider of government services worldwide, today announced it has been awarded a $20 million contract from the Office of Personnel Management (OPM) to serve as the Contact Center Services Provider for the agency's new <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.opm.gov%2Fhealthcare-insurance%2Fpshb%2F&amp;esheet=54113478&amp;newsitemid=20240827600267&amp;lan=en-US&amp;anchor=Postal+Service+Health+Benefits+Program&amp;index=2&amp;md5=0931bc92c966a7e922bc73199a8fda18">Postal Service Health Benefits Program</a>. This program will provide health insurance to eligible Postal Service employees, annuitants, and their eligible family members starting in 2025.
Maximus will be leading the customer support effort to answer calls and emails for OPM's new, enhanced customer service platform dedicated to assisting eligible individuals access health insurance benefits. Maximus will leverage offerings from its Total Experience Management (TXM) solution, including state-of-the-art telephony, customer relationship management, and call quality reporting tools to provide best-in-class customer service.

Maximus Awarded A $20M Contract From The Office Of Personnel Management To Serve As The Contact Center Services Provider For The Agency's New Postal Service Health Benefits Program

Maximus's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMS#NYSE">MMS</a>) short percent of float has risen 9.64% since its last report. The company recently reported that it has 593 thousand shares sold short, which is 1.82% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.92 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Maximus Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1724081411_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Maximus has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Maximus's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Maximus's peer group average for short interest as a percentage of float is 4.88%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

How Is The Market Feeling About Maximus?

Maximus (MMS) announced that the U.S. Department of Health and Human Services, Centers for Medicare & Medicaid Services has withdrawn their early r...

Maximus says it will continue to perform CCO contract

Maximus (MMS) announced it completed the divestiture of all operations in Australia and South Korea, which were reported under the Outside the U.S....

Maximus divests Australia and South Korea operations, expects $100M impact

Maximus authorizes $200 million increase to share buyback program

Maximus (MMS) announced that its Board of Directors has authorized a $200M increase to the purchase program for Maximus common stock, enabling ongo...

Maximus announces $200M increase to share repurchase pact

Raymond James upgraded Maximus (MMS) to Outperform from Market Perform with a $90 price target While 2023 and the first 11 months of 2024 were the ...

Maximus upgraded to Outperform from Market Perform at Raymond James

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President-...

Trump Trade: White House considers leaving U.S. Steel deal decision to Trump

Trump Weekly: Biden blocks U.S. Steel buyout, banks exit climate alliance

MAXIMUS declares $0.30 dividend

Maximus company secures contract for Medical Disability Exam services

Maximus: Navigating Through Some Uncertainty

AAPL

CACI

DAVE

FLNC

GOOG

GOOGL

LDOS

MDBH

MSFT

NISTF

NPSCY

PEGA

PINS

PLTR

RDDT

SNAP

TSLA

TTEC

Press Releases

Maximus Named to $300 Million IRS Consulting Services Blanket Purchase Agreement

Maximus Challenges Early Rebid of 1-800-MEDICARE Contract to U.S. Court of Federal Claims

Maximus Reports Fourth Quarter and Full Year Results for Fiscal Year 2024

U.S. Department of Health and Human Services, Centers for Medicare and Medicaid Services Notify Maximus of Cancellation of the Contact Center Operations Contract Re-Procurement

Comments

Maximus

Maximus (MMS) Forecast

Maximus (NYSE:MMS) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga